THE BIOPHYSICAL HINDRANCE ON MORTALIN FUNCTION FROM EVEN-PLUS SYNDROME MUTATIONS AND MODIFIED ADP ANALOG INHIBITORS
Main Author: | Moseng, Mitchell A. |
---|---|
Language: | English |
Published: |
Miami University / OhioLINK
2019
|
Subjects: | |
Online Access: | http://rave.ohiolink.edu/etdc/view?acc_num=miami1563537216760463 |
Similar Items
-
Optimization of expression and purification of mitochondrial HSP 40 (Tid1-L) chaperone: Role of mortalin and tid1 in the reactivation and amyloid inhibition of proteins
by: Mohammad Rashid Khan, et al.
Published: (2020-11-01) -
Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers
by: Jayarani F. Putri, et al.
Published: (2019-12-01) -
Novel role of mortalin in attenuating HIV-1 Tat-mediated astrogliosis
by: Priyanka, et al.
Published: (2020-09-01) -
Mortalin, Apoptosis, and Neurodegeneration
by: Vivian Gama, et al.
Published: (2012-03-01) -
Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells
by: Dmytro Starenki, et al.
Published: (2019-04-01)